Description

ABIRATAS 250 mg

ABIRATAS 250 mg is a potent formulation containing Abiraterone Acetate, widely used in the treatment of metastatic castration-resistant prostate cancer (mCRPC). It works by selectively inhibiting CYP17, an enzyme critical for androgen production, thereby reducing testosterone levels that fuel prostate cancer growth.

ABIRATAS 250 mg is typically administered alongside prednisone to enhance its therapeutic efficacy and minimize potential side effects. Manufactured under stringent quality standards, it ensures reliable bioavailability and patient compliance.

Trusted by oncologists, ABIRATAS supports improved survival outcomes and better quality of life for patients battling advanced prostate cancer.

Uses 

• Prostate Cancer Treatment – Primarily used to treat metastatic castration-resistant prostate cancer (mCRPC).
• Hormone Therapy Support – Often prescribed alongside prednisone to reduce androgen (male hormone) production that helps cancer grow.
• Androgen Deprivation – Helps in further lowering testosterone levels when traditional hormone therapies are no longer effective.
• Improved Survival – Used to extend survival and delay disease progression in patients with advanced prostate cancer.

How to Use ABIRATAS 250 mg ?

Take ABIRATAS 250 mg exactly as prescribed by your doctor. It is usually taken once daily on an empty stomach—at least one hour before or two hours after a meal. Swallow the tablets whole with water; do not crush or chew them.

It is commonly used with prednisone to enhance effectiveness and reduce side effects. Follow your doctor’s instructions carefully, and do not stop or adjust the dose without medical guidance. Regular monitoring is essential during treatment.

How ABIRATAS 250 mg Works ?

ABIRATAS 250 mg contains Abiraterone Acetate, which works by blocking the CYP17 enzyme, essential for producing androgens (male hormones like testosterone). Prostate cancer cells depend on these hormones to grow and survive.

By inhibiting CYP17, ABIRATAS significantly reduces androgen levels in the body, even those produced outside the testes (like in the adrenal glands or tumor tissue). This hormonal suppression slows cancer progression, relieves symptoms, and improves survival, especially in patients with advanced or resistant prostate cancer.

Dosage

The usual recommended dose of ABIRATAS is 1,000 mg per day, which equals four 250 mg tablets taken orally once daily. It must be taken on an empty stomach—at least one hour before or two hours after a meal—to ensure proper absorption.

ABIRATAS is typically prescribed along with prednisone (5 mg taken twice daily) to reduce the risk of side effects such as high blood pressure or low potassium.

Benefits of ABIRATAS 250 mg

• Slows Cancer Progression – Effectively delays the growth of metastatic castration-resistant prostate cancer (mCRPC).
• Improves Survival – Proven to extend overall survival in men with advanced prostate cancer.
• Hormone Suppression – Reduces androgen levels beyond standard hormone therapy, targeting cancer growth more effectively.
• Enhances Quality of Life – Helps relieve symptoms such as bone pain and urinary issues.
• Convenient Oral Dose – Easy-to-take tablets for daily use at home.
• Used with Prednisone – Enhances treatment outcomes while minimizing side effects.

Side Effects of ABIRATAS 250 mg

• Fatigue – A common side effect due to reduced hormone levels.
• Joint Pain – Some patients may experience discomfort or swelling in their joints.
• High Blood Pressure – ABIRATAS may cause an increase in blood pressure, requiring monitoring.
• Low Potassium Levels – May lead to symptoms like muscle weakness, cramping, or irregular heartbeats.
• Liver Issues – Rarely, it may cause liver enzyme changes, requiring regular liver function tests.
• Hot Flashes – Can occur as a result of hormonal changes.
• Diarrhea or Nausea – Some may experience gastrointestinal discomfort.

Precautions 

• Liver Function – Regular liver tests are required, as ABIRATAS can affect liver enzymes.
• Blood Pressure – Monitor blood pressure regularly, as ABIRATAS may increase it.
• Potassium Levels – Periodic blood tests to check potassium levels are recommended.
• Pregnancy and Women – ABIRATAS is not for use in women, especially during pregnancy, as it may harm the fetus.
• Drug Interactions – Inform your doctor about all other medications to avoid interactions.

Frequently asked question

What is ABIRATAS 250 mg used for?

ABIRATAS 250 mg is primarily used to treat metastatic castration-resistant prostate cancer (mCRPC). It helps slow cancer progression by reducing androgen levels, which prostate cancer cells rely on to grow.

How should I take ABIRATAS 250 mg?

Take four 250 mg tablets once a day, on an empty stomach, at least one hour before or two hours after a meal. Follow your doctor’s instructions regarding dosage and use along with prednisone for optimal results.

What are the common side effects of ABIRATAS 250 mg?

Common side effects include fatigue, joint pain, high blood pressure, low potassium levels, and gastrointestinal issues like diarrhea or nausea. Always report any unusual symptoms to your doctor.

How does ABIRATAS 250 mg work?

ABIRATAS works by inhibiting the CYP17 enzyme, which is involved in androgen production. By lowering androgen levels, it reduces the growth and spread of prostate cancer cells.

Are there any precautions I should take when using ABIRATAS 250 mg?

Regularly monitor liver function and blood pressure. Ensure potassium levels are checked, and inform your doctor about any other medications. ABIRATAS is not recommended for use in women, especially during pregnancy.

Can ABIRATAS 250 mg be taken with other medications?

ABIRATAS may interact with other medications, so it’s important to inform your doctor of all the drugs you’re currently taking, including over-the-counter medications and supplements.

Conclusion

In conclusion, ABIRATAS 250 mg is an effective treatment for metastatic castration-resistant prostate cancer, helping slow cancer progression and improve survival. By lowering androgen levels, it targets the root cause of cancer growth.

While side effects and precautions are important to consider, with proper monitoring and medical supervision, ABIRATAS offers a significant therapeutic benefit.